| BIO-TECHNE CORP. DL-,01 |
| USA |
| Gesundheit |
| US09073M1045 / A12ENG |
| TE1 (Frankfurt) / TECH (NASDAQ) |
| FRA:TE1, ETR:TE1, TE1:GR, NASDAQ:TECH |
| S&P500 |
| https://www.bio-techne.co.. |
|
Bio-Techne Corporation is a global life sciences company that develops, manufactures, and supplies specialized tools for research and clinical diagnostics. The company focuses on high-quality reagents, analytical instruments, and precision diagnostic..
>Volltext.. |
| 7649.91 Mio. EUR |
| 7719.87 Mio. EUR |
| 1063.84 Mio. EUR |
| 324.08 Mio. EUR |
| 96.23 Mio. EUR |
| 0.62 EUR |
| 255.08 Mio. EUR |
| 184.35 Mio. EUR |
| 259.07 Mio. EUR |
| 1.37 |
| -6.21% |
| -22.1% |
| 0.27 EUR |
| 0.58% |
| 0.57% |
| 18.05.26 - 0.068816€ 13.02.26 - 0.067392€ >weitere anzeigen... |
| - |
| BIO-TECHNE, BIO TECHNE |
| 25.06.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|